Who Owns TCRT?

Alaunos Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$2.67

-0.09 (-3.25%)

Market Cap

$8.1M

Shares Outstanding

2,378,250

Institutional Holders

29

Total Inst. Value

$100K

% of Float Held

QoQ Holder Change

+28

Institutional data as of Q1 2025

New Positions

6

Closed Positions

5

Increased

3

Decreased

6

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BlackRock, Inc.$31K21,353
2VANGUARD GROUP INC$29K20,972
3GEODE CAPITAL MANAGEMENT, LLC$22K15,610
4UBS Group AG$12K7,869
5Tower Research Capital LLC (TRC)$2K1,676
6OSAIC HOLDINGS, INC.$1K720
7MORGAN STANLEY$1K897
8CIBC Private Wealth Group LLC$753300
9GROUP ONE TRADING LLC$435300
10WELLS FARGO & COMPANY/MN$318216

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold TCRT?

As of Q1 2025, 29 institutional investors report holding TCRT (Alaunos Therapeutics, Inc.) in their 13F filings.

Which hedge fund owns the most TCRT?

The largest institutional holder of TCRT is BlackRock, Inc. with $31K in shares.

Are institutions buying or selling TCRT?

This quarter, 6 institutions opened new positions in TCRT and 5 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.